Skip to main content
. 2022 Feb 22;13(3):6012–6023. doi: 10.1080/21655979.2022.2042133

Figure 1.

Figure 1.

Elevated FOXD3-AS1 was observed in GBM and is correlated with poor prognosis.

(A) According to the TCGA dataset, FOXD3-AS1 expression was upregulated in GBM patient tissue samples (*p < 0.05). (B) According to the TCGA dataset, level of FOXD3-AS1 was remarkably higher in higher WHO grade of GBM patient. (*p < 0.05) (C) qRT-PCR results showed that FOXD3-AS1 expression was increased in different GBM cell lines compared to normal NHA cells (N = 3, *p < 0.05). (D) Kaplan–Meier analysis indicated that a higher level of FOXD3-AS1 indicated worse prognosis for GBM patients.